Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Entrada Therapeutics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Prev close 6.88 · gapped below the open, then crossed back over prior close. High/low 6.94 at 2:00 pm ET, 6.70 at 10:45 am ET.
128 institutional managers report a position in Entrada Therapeutics, Inc. worth $214.2M between them, filed on form 13F for the quarter ending 2026-06-30. 17 of them hold 80% of it, the largest being Baker Bros. Advisors LP at 17.43%.
103 more managers in the register
17 managers hold 80% of the $214.2M institutional base. The other 111 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
TRDA (Entrada Therapeutics, Inc.) has 2 disclosed suppliers and 2 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: VRTX +0.94%, in healthcare.
via 5AM Venture Management, LLC, Baker Bros. Advisors LP · 13.94% of TRDA, 59.96% of SKYE
via Baker Bros. Advisors LP, TCG Crossover Management, LLC, Wellington Management Group LLP · 17.43% of TRDA, 32.23% of KOD
via Baker Bros. Advisors LP, Acadian Asset Management LLC, Moore Capital Management, LP · 17.43% of TRDA, 28.87% of BCYC
via Baker Bros. Advisors LP, Acadian Asset Management LLC · 17.43% of TRDA, 20.29% of PRLD
via Baker Bros. Advisors LP, Wellington Management Group LLP, Acadian Asset Management LLC +2 more · 17.43% of TRDA, 15.21% of INCY
via Baker Bros. Advisors LP, Allspring Global Investments Holdings, LLC · 17.43% of TRDA, 25.37% of ACAD
Managers holding a meaningful stake in TRDA also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.